Acorda

is a New York-based biotechnology company that researches and develops neurology therapies for the treatment of Parkinson disease, migraine and multiple sclerosis...
Read more
Acorda President & CEO: Ron Cohen

President & CEO

Ron Cohen

CEO Approval Rating

87/100

Annual Revenue
$115.7M
Employees
102
Funding
$182.3M
Acquisitions
3

Acorda Competitors

1Alexza
2Pulmatrix
3Vectura
4MannKind
5InVivo
6Merck
7Pfizer
8Advanced Cancer Therapeutics, LLC
9Cynapsus
10Novartis

Trending Companies